Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

This study has been terminated.
(poor enrollment)
Information provided by:
Epeius Biotechnologies Identifier:
First received: July 15, 2005
Last updated: December 15, 2007
Last verified: December 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given